Current efficacy of hepatic arterial infusion chemotherapy in hepatocellular carcinoma

doi:10.4251/wjgo.v16.i12.4766

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 12

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (726)

All Articles published online

The chart showing PDF series, HTML series, Tables (1-1) series.

Item

Count

PDF

HTML

427

Tables (1-1)

109

Sum=558

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=126

Dec 15, 2024 (publication date) through Feb 7, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Letter to the Editor

World J Gastrointest Oncol. Dec 15, 2024; 16(12): 4766-4769
Published online Dec 15, 2024. doi: 10.4251/wjgo.v16.i12.4766

Current efficacy of hepatic arterial infusion chemotherapy in hepatocellular carcinoma

Douglas Dias E Silva, Mitesh Borad, Pedro Luiz Serrano Uson Junior

Douglas Dias E Silva, Department of Oncology, Hospital Israelita Albert Einstein, São Paulo 05652900, Sao Paulo, Brazil

Mitesh Borad, Division of Hematology-Oncology, Department of Medicine, Mayo Clinic Arizona, Mayo Clinic Cancer Center, Phoenix, AZ 85054, United States

Pedro Luiz Serrano Uson Junior, Center for Personalized Medicine, Hospital Israelita Albert Einstein, São Paulo 05652900, Sao Paulo, Brazil

Author contributions: Dias e Silva D, Borad M, and Uson Junior PLS wrote and revised the article, reviewed the literature, and approved the final version of the manuscript.

Conflict-of-interest statement: The authors declare no conflicts-of-interest.

Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Pedro Luiz Serrano Uson Junior, MD, Assistant Professor, Center for Personalized Medicine, Hospital Israelita Albert Einstein, Avenida Albert Einstein 627, São Paulo 05652900, Sao Paulo, Brazil. pedro.serrano@einstein.br

Received: July 21, 2024
Revised: August 28, 2024
Accepted: October 12, 2024
Published online: December 15, 2024
Processing time: 113 Days and 17.8 Hours

Core Tip

Core Tip: This meta-analysis provides a valuable and comprehensive evaluation of hepatic arterial infusion chemotherapy (HAIC) and its combination therapies for advanced hepatocellular carcinoma. Compared to other treatments including transarterial chemoembolization, HAIC showed favorable outcomes including response rate and survival. Furthermore, based on the findings, combination of HAIC with antiangiogenics and even immune checkpoint inhibitors seems to improve efficacy when compared to HAIC alone.